⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3034748 | 1.00 | — | — | |
| SCHEMBL8274310 | 1.00 | — | — | |
| SCHEMBL17565687 | 0.88 | — | — | |
| SCHEMBL4120715 | 0.84 | ALDH1A1 (0.52) | — | |
| SCHEMBL4120718 | 0.84 | ALDH1A1 (0.52) | — | |
| SCHEMBL820895 | 0.82 | TSHR (0.46) | — | |
| SCHEMBL821048 | 0.82 | TSHR (0.46) | — | |
| SCHEMBL820889 | 0.82 | TSHR (0.46) | — | |
| SCHEMBL11784960 | 0.82 | TSHR (0.46) | — | |
| SCHEMBL17581088 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2742153-A1 | PROTEIN AND PEPTIDE LIBRARIES | The General Hospital Corporation (US) | 2014-06-18 | — | — | EP | claimed |
| WO-2013019794-A1 | PROTEIN AND PEPTIDE LIBRARIES | THE GENERAL HOSPITAL CORPORATION (US) | 2013-02-07 | — | — | WO | claimed |
| JP-58121286-A | — | — | None | — | — | JP | disclosed |
| JP-56086128-A | — | — | None | — | — | JP | disclosed |
| US-11116212-B2 | Carbonyl containing compounds for controlling and repelling Cimicidae populations | SEMIOSBIO TECHNOLOGIES INC. (CA) | 2021-09-14 | — | — | US | disclosed |
| US-11116212-B2 | Carbonyl containing compounds for controlling and repelling Cimicidae populations | SEMIOSBIO TECHNOLOGIES INC. (CA) | 2021-09-14 | — | — | US | disclosed |
| CN-111747837-A | Synthesis method of trans-4-oxo-2-hexenal | 苏州华道生物药业股份有限公司 | 2020-10-09 | — | — | CN | disclosed |
| EP-2742153-B1 | PROTEIN AND PEPTIDE LIBRARIES | MASSACHUSETTS GEN HOSPITAL (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9708363-B2 | Method for cross-linking peptides | UNIVERSITEIT GENT (BE) | 2017-07-18 | — | — | US | disclosed |
| US-20170198282-A1 | PROTEIN AND PEPTIDE LIBRARIES | THE GENERAL HOSPITAL CORPORATION (US) | 2017-07-13 | — | — | US | disclosed |
| US-20160244481-A1 | METHOD FOR CROSS-LINKING PEPTIDES | UNIVERSITEIT GENT (BE) | 2016-08-25 | — | — | US | disclosed |
| US-7427675-B2 | Compounds and methods for the characterization of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2008-09-23 | — | — | US | disclosed |
| US-7427675-B2 | Compounds and methods for the characterization of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2008-09-23 | — | — | US | disclosed |
| WO-2007124494-A2 | ENANTIOSELECTVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-11-01 | — | — | WO | disclosed |
| WO-2006023880-A2 | COMPOUNDS AND METHODS FOR THE CHARACTERIZATION OF OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20060040308-A1 | Compounds and methods for the characterization of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2006-02-23 | — | — | US | disclosed |
| JP-S58121286-A | 4-ALKYLTHIO-2-METHYLFURAN COMPOUND AND ITS USE | T HASEGAWA CO LTD | 1983-07-19 | — | — | JP | disclosed |
| JP-S5686128-A | PRODUCTION OF CYCLOPENTENONE | TEIJIN LTD | 1981-07-13 | — | — | JP | disclosed |
| US-3996287-A | SULFURIZATION OF A 2-ENE-1,4-DIONE; HYDROLYZING | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3931270-A | Process for producing 2-thia substituted 1,4 diones | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-01-06 | — | — | US | disclosed |